vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and COLONY BANKCORP INC (CBAN). Click either name above to swap in a different company.
AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $39.9M, roughly 1.1× COLONY BANKCORP INC). COLONY BANKCORP INC runs the higher net margin — 20.6% vs -19.9%, a 40.5% gap on every dollar of revenue. Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 19.6%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Colony Bankcorp Inc is a US-based bank holding company that operates Colony Bank. It provides a full suite of personal and commercial banking services including deposit accounts, consumer and business loans, mortgage services, and wealth management solutions, primarily serving retail customers and small-to-medium enterprises across the state of Georgia.
ABCL vs CBAN — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $39.9M |
| Net Profit | $-8.9M | $8.2M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | — |
| Net Margin | -19.9% | 20.6% |
| Revenue YoY | 788.4% | — |
| Net Profit YoY | 73.9% | 24.1% |
| EPS (diluted) | $-0.03 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $39.9M | ||
| Q4 25 | $44.9M | $36.9M | ||
| Q3 25 | $9.0M | $32.8M | ||
| Q2 25 | $17.1M | $32.5M | ||
| Q1 25 | $4.2M | $30.0M | ||
| Q4 24 | $5.0M | $30.8M | ||
| Q3 24 | $6.5M | $28.6M | ||
| Q2 24 | $7.3M | $27.9M |
| Q1 26 | — | $8.2M | ||
| Q4 25 | $-8.9M | — | ||
| Q3 25 | $-57.1M | $5.8M | ||
| Q2 25 | $-34.7M | $8.0M | ||
| Q1 25 | $-45.6M | $6.6M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-51.1M | $5.6M | ||
| Q2 24 | $-36.9M | $5.5M |
| Q1 26 | — | — | ||
| Q4 25 | -63.7% | 25.9% | ||
| Q3 25 | -851.8% | 22.2% | ||
| Q2 25 | -290.2% | 30.9% | ||
| Q1 25 | -1479.6% | 27.6% | ||
| Q4 24 | — | 28.8% | ||
| Q3 24 | -1439.4% | 24.6% | ||
| Q2 24 | -1276.2% | 24.8% |
| Q1 26 | — | 20.6% | ||
| Q4 25 | -19.9% | — | ||
| Q3 25 | -637.8% | 17.7% | ||
| Q2 25 | -203.3% | 24.6% | ||
| Q1 25 | -1077.2% | 22.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | -785.4% | 19.7% | ||
| Q2 24 | -504.3% | 19.6% |
| Q1 26 | — | — | ||
| Q4 25 | $-0.03 | $0.42 | ||
| Q3 25 | $-0.19 | $0.33 | ||
| Q2 25 | $-0.12 | $0.46 | ||
| Q1 25 | $-0.15 | $0.38 | ||
| Q4 24 | — | $0.43 | ||
| Q3 24 | $-0.17 | $0.32 | ||
| Q2 24 | $-0.13 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $295.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $380.4M |
| Total Assets | $1.4B | $3.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $295.8M | ||
| Q4 25 | $128.5M | — | ||
| Q3 25 | $83.2M | — | ||
| Q2 25 | $92.4M | — | ||
| Q1 25 | $159.3M | — | ||
| Q4 24 | $156.3M | — | ||
| Q3 24 | $126.6M | — | ||
| Q2 24 | $148.3M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $258.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $248.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $380.4M | ||
| Q4 25 | $966.9M | $375.9M | ||
| Q3 25 | $964.0M | $302.3M | ||
| Q2 25 | $1.0B | $293.9M | ||
| Q1 25 | $1.0B | $286.9M | ||
| Q4 24 | $1.1B | $278.7M | ||
| Q3 24 | $1.1B | $276.1M | ||
| Q2 24 | $1.1B | $264.7M |
| Q1 26 | — | $3.7B | ||
| Q4 25 | $1.4B | $3.7B | ||
| Q3 25 | $1.4B | $3.2B | ||
| Q2 25 | $1.4B | $3.1B | ||
| Q1 25 | $1.3B | $3.2B | ||
| Q4 24 | $1.4B | $3.1B | ||
| Q3 24 | $1.4B | $3.1B | ||
| Q2 24 | $1.4B | $3.0B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.69× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.89× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | — |
| Free Cash FlowOCF − Capex | $-44.6M | — |
| FCF MarginFCF / Revenue | -99.4% | — |
| Capex IntensityCapex / Revenue | 21.9% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-34.7M | $-5.5M | ||
| Q3 25 | $-52.6M | $14.4M | ||
| Q2 25 | $-32.4M | $15.8M | ||
| Q1 25 | $-11.6M | $17.9M | ||
| Q4 24 | $-108.6M | $23.4M | ||
| Q3 24 | $-28.9M | $20.5M | ||
| Q2 24 | $-30.0M | $1.1M |
| Q1 26 | — | — | ||
| Q4 25 | $-44.6M | $-6.9M | ||
| Q3 25 | $-61.5M | $14.1M | ||
| Q2 25 | $-45.8M | $15.8M | ||
| Q1 25 | $-22.2M | $17.6M | ||
| Q4 24 | $-187.0M | $22.3M | ||
| Q3 24 | $-47.4M | $20.2M | ||
| Q2 24 | $-50.1M | $990.0K |
| Q1 26 | — | — | ||
| Q4 25 | -99.4% | -18.7% | ||
| Q3 25 | -687.0% | 42.9% | ||
| Q2 25 | -267.9% | 48.5% | ||
| Q1 25 | -524.0% | 58.7% | ||
| Q4 24 | -3702.8% | 72.5% | ||
| Q3 24 | -728.4% | 70.6% | ||
| Q2 24 | -683.8% | 3.5% |
| Q1 26 | — | — | ||
| Q4 25 | 21.9% | 3.7% | ||
| Q3 25 | 99.7% | 1.1% | ||
| Q2 25 | 78.2% | 0.3% | ||
| Q1 25 | 251.1% | 1.2% | ||
| Q4 24 | 1552.7% | 3.5% | ||
| Q3 24 | 284.6% | 1.0% | ||
| Q2 24 | 274.6% | 0.5% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 2.48× | ||
| Q2 25 | — | 1.99× | ||
| Q1 25 | — | 2.71× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.64× | ||
| Q2 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCL
Segment breakdown not available.
CBAN
| Net Interest Income | $29.2M | 73% |
| Noninterest Income | $10.7M | 27% |
